Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue SUPPL. 1, 2007, Pages

  Kisseleva, Tatiana ^a   Brenner, David A ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Columbia University Medical Center College of Physicians and Surgeons PH 8E 105 J ^*  (United States)

Author keywords

Collagen type I; Hepatic stellate cells; Liver fibrosis

Indexed keywords

ANGIOTENSIN II; CD1B ANTIGEN; CD1C ANTIGEN; COLLAGEN TYPE 1; LEPTIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN PRESENTATION; APOPTOSIS; CELL TYPE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CYTOKINE RELEASE; FIBROGENESIS; INFLAMMATORY CELL; LIVER CELL; LIVER FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STELLATE CELL;

EID: 34249776715     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04658.x     Document Type: Conference Paper

References (27)

1. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 2001 21 : 437 51.
2. Bataller R, Brenner DA. Liver fibrosis. J. Clin. Invest. 2005 115 : 209 18.
3. Sudo K, Yamada Y, Moriwaki H, Saito K, Seishima M. Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice. Cytokine 2005 29 : 236 44.
4. Wynn TA. Fibrotic disease and the T (H) 1/T (H) 2 paradigm. Nat. Rev. Immunol. 2004 4 : 583 94.
5. Solis Herruzo JA, de la Torre P, Diaz Sanjuan T, Garcia Ruiz I, Munoz Yague T. IL-6 and extracellular matrix remodeling. Rev. Esp. Enferm. Dig. 2005 97 : 575 95.
6. Bataller R, Schwabe RF, Choi YH et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 2003 112 : 1383 94.
7. Hillebrandt S, Wasmuth HE, Weiskirchen R et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat. Genet 2005 37 : 835 43.
8. Faouzi S, Burckhardt BE, Hanson JC et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J. Biol. Chem. 2001 276 : 49077 82.
9. Canbay A, Gieseler RK, Gores GJ, Gerken G. The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic. Z. Gastroenterol. 2005 43 : 211 17.
10. Stefanovic L, Brenner DA, Stefanovic B. Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp. Biol. Med. (Maywood) 2005 230 : 573 86.
11. McVicker BL, Tuma DJ, Kubik JA, Hindemith AM, Baldwin CR, Casey CA. The effect of ethanol on asialoglycoprotein receptor-mediated phagocytosis of apoptotic cells by rat hepatocytes. Hepatology 2002 36 : 1478 87.
12. Dalton SR, Wiegert RL, Baldwin CR, Kassel KM, Casey CA. Impaired receptor-mediated endocytosis by the asialoglycoprotein receptor in ethanol-fed mice: implications for studying the role of this receptor in alcoholic apoptosis. Biochem. Pharmacol. 2003 65 : 535 43.
13. Vinas O, Bataller R, Sancho-Bru P et al. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 2003 38 : 919 29.
14. Pinzani M, Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig. Liver Dis. 2004 36 : 231 42.
15. Breitkopf K, Haas S, Wiercinska E, Singer MV, Dooley S. Anti-TGF-beta strategies for the treatment of chronic liver disease. Alcohol Clin. Exp. Res. 2005 29 : 121S 131S.
16. Kmiec Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 2001 161 : III XIII, 1 151.
17. Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int. Suppl. 1996 54 : S39 45.
18. Arthur MJ. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2000 279 : G245 9.
19. Ueberham E, Low R, Ueberham U, Schonig K, Bujard H, Gebhardt R. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 2003 37 : 1067 78.
20. Knittel T, Dinter C, Kobold D et al. Expression and regulation of cell adhesion molecules by hepatic stellate cells (HSC) of rat liver: involvement of HSC in recruitment of inflammatory cells during hepatic tissue repair. Am. J. Pathol. 1999 154 : 153 67.
21. Siegmund SV, Brenner DA. Molecular pathogenesis of alcohol-induced hepatic fibrosis. Alcohol Clin. Exp. Res. 2005 29 : 102S 109S.
22. Svegliati-Baroni G, Saccomanno S, van Goor H, Jansen P, Benedetti A, Moshage H. Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver 2001 21 : 1 12.
23. Xiao HD, Fuchs S, Frenzel K, Teng L, Bernstein KE. Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE). Crit Rev. Eukaryot. Gene. Expr. 2004 14 : 137 45.
24. Kurdi M, De Mello WC, Booz GW. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. Int. J. Biochem. Cell Biol. 2005 37 : 1357 67.
25. Brasier AR, Recinos A 3rd, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler. Thromb. Vasc. Biol. 2002 22 : 1257 66.
26. Iredale JP. Hepatic stellate cell behavior during resolution of liver injury. Semin. Liver Dis. 2001 21 : 427 36.
27. Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 2006 130 : 435 52.